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How intramolecular hydrogen bonding (IHB)
controls the C–ON bond homolysis in
alkoxyamines†
Gérard Audran,*a Raphael Bikanga,b Paul Brémond,a Mariya Edeleva, c
Jean-Patrick Joly,a Sylvain R. A. Marque, *a,c Paulin Nkoloa and Valérie Roubauda
Recent amazing results (Nkolo et al., Org. Biomol. Chem., 2017, 6167) on the effect of solvents and
polarity on the C–ON bond homolysis rate constants kd of alkoxyamine R1R2NOR3 led us to re-investi-
gate the antagonistic effect of intramolecular hydrogen-bonding (IHB) on kd. Here, IHB is investigated
both in the nitroxyl fragment R1R2NO and in the alkyl fragment R3, as well as between fragments, that is,
the donating group on the alkyl fragment and the accepting group on the nitroxyl fragment, and con-
versely. It appears that IHB between fragments (inter IHB) strikingly decreases the homolysis rate con-
stant kd, whereas IHB within the fragment (intra IHB) moderately increases kd. For one alkoxyamine, the
simultaneous occurrence of IHB within the nitroxyl fragment and between fragments is reported. The
protonation effect is weaker in the presence than in the absence of IHB. A moderate solvent effect is
also observed.
Introduction
Since the pioneering work of Rizzardo and co-workers,1,2
alkoxyamines have been applied in several fields such as tin-
free radical organic chemistry3,4 – as initiators for radical cycli-
zation,5,6 1,2-radical additions,7 and several others5 – NMP
(nitroxide mediated polymerization) and its variants: in situ
NMP,8 ESCP,9 NMP2,10,11 SL-NMP,12 and CI-NMP,13 materials
sciences – for self-healing polymers,14 optoelectronic
materials,15 and encoding systems16 – and in biology,17–19 as
agents for theranostics. For alkoxyamines to be used as agents
for theranostics (Fig. 1), the concept of a “smart” alkoxyamine
was proposed,17 that is, a highly stable alkoxyamine switching
to a highly labile alkoxyamine through chemical reactions
(Fig. 2). For several years, our group has been promoting the
chemical alkoxyamine activation using protonation,20 oxi-
dation,20 alkylation,20 or metal cation coordination.21,22
However, in our view, activation processes based on physico-
chemical events cannot be disregarded. Indeed, very recently,23
a dramatic solvent effect on the C–ON bond homolysis rate
constant kd (Scheme 1) has been reported for 1 (Fig. 3).
Intramolecular hydrogen-bonding (IHB) displays very different
trends, that is, IHB within the nitroxyl fragment affords an
Fig. 1 Concept for the application of alkoxyamines as agents for thera-
nostics. Reproduced with permission of the American Chemical Society
(see ref. 46).
†Electronic supplementary information (ESI) available: 1H, 13C NMR and HRMS
spectra of 2–7 and 2•. DFT calculations for the most stable conformers of 4 and
6. A gradient profile for flash chromatography. The titration curve for 2-hydroxy-
ethylpyridine, and XRD for RR/SS-4 and RS/SR-6. CCDC 1550955 and 1550956.
For ESI and crystallographic data in CIF or other electronic format see DOI:
10.1039/c7ob02223a
aAix Marseille Univ, CNRS, ICR, UMR 7273, case 551, Avenue Escadrille Normandie-
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increase in kd (Fig. 4a)
24–27 and IHB from the alkyl fragment to
the nitroxyl fragment (interR, Fig. 4c) affords a decrease in
kd spanning from weak (2–3 kJ mol
−1)28 to moderate29
(ca. 10 kJ mol−1). Interestingly, other types of IHBs have not yet
been investigated – IHB from the nitroxyl fragment to the alkyl
fragment (interN, Fig. 4d) and IHB within the alkyl fragment
(Fig. 4b) – and are the focus of this article. Several models 2–7
(Fig. 3) were prepared and their structures were determined by
X-ray and NMR analysis.
The occurrence and the type of IHB were determined by
combining 31P and 1H NMR with DFT calculations. The influ-
ence of IHB on kd was investigated in tert-butylbenzene
(t-BuPh) as a non-polar solvent and water as a polar/hydrogen
bond acceptor (HBA) solvent, known to suppress IHB.30
Results
Preparation of alkoxyamines 2–7
Alkoxyamine 3 was prepared either as previously reported26
(black route in Scheme 2) or by the hydrolysis31 of 2 prepared
from protected amino alcohol 2a (blue and magenta routes in
Scheme 2). Alkoxyamine 2 was prepared either by the protec-
tion32 of 3 (black route in Scheme 2) or from the protected
phosphorylated amino alcohol 2b (magenta route in
Scheme 2).
Alkoxyamine 4 was prepared using the conventional Mn
(salen)2 salt procedure (Scheme 3).
33 The two diastereoisomers
Fig. 2 Concept for “smart” alkoxyamines. Reproduced with permission
of the Royal Society of Chemistry (see ref. 17).
Scheme 1 C–ON bond homolysis in alkoxyamines.
Fig. 4 Various types of IHBs: (a) within the nitroxyl fragment (intraN),
(b) within the alkyl fragment (intraR), (c) from alkyl to nitroxyl fragments
(interR), and (d) from nitroxyl to alkyl fragments (interN). Dotted blue
lines represent IHB.
Fig. 3 Alkoxyamines and nitroxides discussed in the article.
Paper Organic & Biomolecular Chemistry
8426 | Org. Biomol. Chem., 2017, 15, 8425–8439 This journal is © The Royal Society of Chemistry 2017
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
7 
Se
pt
em
be
r 2
01
7.
 D
ow
nl
oa
de
d 
on
 1
2/
06
/2
01
8 
14
:3
9:
18
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
were separated and RR/SS-4 ‡ was recrystallized. Then, it was
protected using t-BuMe2SiCl to afford 5 in good yield
(Scheme 3).34 §
Alkoxyamine 6 was prepared from the corresponding
bromide 6b coupled to 6• using the conventional ATRA pro-
cedure.35 However, 7 was obtained as a crude mixture of dia-
stereoisomers which cannot be separated. Then, crude 7 was
hydrolyzed into crude 6 whose diastereoisomers were separ-
ated, and the diastereoisomer RS/SR‡ was crystallized. The dia-
stereoisomers of 6 were acetylated into 7 (Scheme 4).
X-ray analysis
Alkoxyamines RR/SS-4 and RS/SR-6 were crystallized and ana-
lyzed by XRD (Fig. 5).‡ X-ray structures exhibit the convention-
al distances and angles observed for such types of molecules
(see the ESI†). Dihedral angles <O5C6C7N8> are 45° and 90°
larger (Fig. 6d) than the 90° required at TS for RR/SS-4 and RS/
SR-6, respectively.36 However, from the X-ray structure (Fig. 5
and 6) it is clear that no IHB occurs in RR/SS-4 in the solid
state although it is a good model to observe IHB of type (a) or
(d) (Fig. 4) or both. By contrast, RS/SR-6, which is a good
model for IHB of type (b) or (c) or both (Fig. 4), exhibits only
IHB of type (c).¶ 37,38 The absence of IHB in the RR/SS-4 X-ray
structure is in sharp contrast with its occurrence in solution
(vide infra). This difference in conformation between the
crystal and solution has already been observed several times
for alkoxyamines27,28 and it is ascribed to the packing effect,
which forces intermolecular H-bonding at the expense of IHB.
NMR analysis
In contrast with XRD, 1H and 31P NMR spectra show that IHBs
of types (a) and (d) occur at the same time for RR/SS-4.∥ As
already reported for 2 and 3,29 Δδ for 4 and 5 decreases from
benzene-d6 to DMSO-d6 (Table 1 and Fig. 7), as expected from
the increase in the parameter β30 – the hydrogen bond accep-
tor (HBA) property of the solvent – that is, the increase in the
ability to suppress IHB. The occurrence of IHB between the di-
ethylphosphoryl and the hydroxyl groups (intraN in Fig. 8) is
supported by the difference in shifts δ and the signal pattern
for the MeCH2O group observed between RR/SS-4 and RR/SS-5
in benzene-d6 (protons labelled a in Fig. 9)** and its suppres-
sion in DMSO-d6 (very similar patterns for protons labelled a–c
for RR/SS-4 and RR/SS-5 in Fig. 9). However, the chemical
shifts δ and the signal pattern of pyridyl protons (Fig. 9) are
very different for RR/SS-4 and RR/SS-5 in benzene-d6, while
they are similar in DMSO-d6. As similar observations were also
reported upon protonation (or other types of activation) of the
pyridyl moiety in alkoxyamines,20–22 this change in the signal
is ascribed to the occurrence of IHB between the hydroxyl
group and the pyridyl moiety (interN in Fig. 8). Temperature
Scheme 2 Preparation of 2 and 3: (a) (1) 2a or 3a (1.1 eq.), t-Bu-CHO
(1 eq.), pentane, 65 °C, 2 day, (2) (EtO)2P(O)H (1.1 eq.), 45 °C, 7 days,
64–78%; (b) 2b or 3b (1 eq.), Oxone® (4 eq.), Na2CO3 (6 eq.), EtOH/H2O
(3 : 1), 5 h, rt, 51–56%; (c) (1) Cu(0) (1.1 eq.), CuBr (0.55 eq.), PMDETA
(0.55 eq.), argon bubbled benzene, 30 min, rt, (2) 1-bromoethylbenzene
(1.1 eq.), 2• or 3• (1 eq.), rt, overnight, 65–72%; (d) 3a, 3b, or 3 (1 eq.),
t-BuMe2SiOTf (1.5 eq.), 2,6-lutidine (2 eq.), DCM, 4 h, rt 80–90%; (e) 2
(1 eq.) TBAF (1 M in THF) (1.2 eq.), THF, rt, 92%.
Scheme 3 Preparation of 4 and 5: (a) (1) salen ligand (0.05 eq.), MnCl2
(0.05 eq.), i-PrOH, 30 min, rt; (2) 3• (1 eq.), 2-vinyl pyridine (1 eq.),
i-PrOH; (3) NaBH4 (5 eq.), 4 h, rt, 54%; (b) (1) 4 (1eq.), pyridine (5 eq.),
AgNO3 (1.5 eq.), THF, 5 min, rt; (2) t-BuMe2SiCl (1.5 eq.), overnight, rt,
59–67%.
Fig. 5 X-ray structures for RR/SS-4 (left) and RS/SR-6 (right).‡
Scheme 4 Preparation of 6 and 7: (a) 5a (1 eq.), NBS (1.1 eq.), benzoyl
peroxide (0.1 eq.), CCl4, reflux, 69%; (b) (1) CuBr (0.5 eq.), Cu(0) (1 eq.),
PMEDTA (0.5 eq.), benzene, Ar, 10 min, rt; (2) 6• (1.1 eq.), 6b (1 eq.),
benzene, 12 h, rt, (3) MeOH, K2CO3, H2O, 3 days, rt, 63%; (c) (1) 6 (1 eq.),
Et3N (4 eq.), CH2Cl2; (2) Ac2O (3 eq.), 3 days, rt, 65–90%.
‡CCDC: 1550955 for RR/SS-4 and 1550956 for RS/SR-6.†
§The procedure described in Scheme 2 was not used because it afforded the iso-
merization of the pure diastereoisomer.
¶dPvO⋯HO = 1.96 Å and <O1H15O14> = 164°. The bond radii of H, N and O are
rH = 1.09 Å, rN = 1.55 Å and rO = 1.52 Å, respectively. See ref. 37.
∥RR/SS-5 exhibiting no IHB was chosen as a model for 4 and very similar solvent
effects were expected.
**Protons from CH2OH (labelled e in Fig. 9) are expected to be sensitive to the
silylation of the hydroxyl functions, whereas protons labelled b and c are not
expected to be very sensitive.
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dependence shows only line broadening when the temperature
is decreased down to −80 °C, meaning that the rotation
around the C–N bond of the group carrying the hydroxyl func-
tion is faster than the resolution time of 1H NMR. DFT calcu-
lations (vide infra) led us to disregard the occurrence of
3-center IHB, as shown in Fig. 8.
The same trends are observed for Δδ (Fig. 7 and Table 1)
and 1H NMR signals of EtO protons (labelled a in Fig. 1SI†) for
RS/SR diastereoisomers of 4 and 5 as those for diastereo-
isomers RR/SS and are ascribed to the occurrence of IHB
between the diethylphosphoryl and the hydroxyl groups
(Fig. 10). In sharp contrast to what was observed for the dia-
stereoisomer RR/SS, no significant differences in chemical
shifts and signal patterns in the pyridyl proton zone are
observed for RS/SR-4 and RS/SR-5, whatever the solvent
(Fig. 1SI†). Consequently, only intraN IHB (type (a) in Fig. 4) is
observed in RS/SR-4 (Fig. 10a).
The same trends are observed for Δδ (Fig. 11b and Table 2)
and 1H NMR signals of EtO protons (labelled a in Fig. 2SI†) for
RS/SR diastereoisomers of 6 and 7 as those for 4 and 5 (vide
Fig. 6 Cram (a) and Newman projections through (b) N4–O5, (c) O5–C6, (d) C6–C7, and (e) C3–N4 bonds for RR/SS-4 (top) and RS/SR-6 (bottom).
Table 1 Solvent effect on diastereoisomers of 4 and 5 investigated by
31P NMR
Solventa βb
δ (ppm)
Δδd
(ppm)
δ (ppm)
Δδd
(ppm)
RR/
SS-4 c
RR/
SS-5 c
RS/
SR-4 c
RS/
SR-5 c
CDCl3 0.10 27.29 26.11 1.18 26.13 25.22 0.91
C6D6 0.10 27.35 25.86 1.49 26.29 24.95 1.34
CD3CN 0.40 27.17 26.25 0.92 26.57 25.25 1.32
Acetone-
d6
0.48 27.27 26.31 0.96 26.69 25.21 1.48
CD3OD 0.66 27.32 27.04 0.28 26.42 26.02 0.40
DMSO-
d6
0.76 26.46 26.15 0.31 25.61 24.95 0.66
a 85% H3PO4 was used as an internal reference (0 ppm).
bHydrogen
bond acceptor parameter β. Given in ref. 30. c Ratio 4 : 5 = 2 : 1. dΔδ =
δ4 − δ5.
Fig. 7 31P NMR signals in various solvents for (a) a (2 : 1) mixture of RR/
SS-4 (left) and RR/SS-5 (right), and (b) a (2 : 1) mixture of RS/SR-4 (left)
and RS/SR-5 (right).
Fig. 9 1H NMR spectra of RR/SS-4 (top) and RR/SS-5 (bottom) in the
range 2.5–6 ppm (top row) and 6–9 ppm (pyridyl proton zone, bottom
row) in benzene-d6 (left) and DMSO-d6 (right). Labelling of protons: a–e
represent MeCH2O, CHP, CHMe, OH, and CH2O, respectively.
Fig. 8 Possible conformations affording intraN IHB (left), interN IHB
(middle), and 3-center IHB (right) for RR/SS-4.
Paper Organic & Biomolecular Chemistry
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supra) and are ascribed to the occurrence of IHB between the
diethylphosphoryl and the hydroxyl groups (Fig. 6) in RS/SR-6.
On the other hand, the very similar signal patterns of protons
in the aromatic zone for RS/SR-6 and RS/SR-7 (Fig. 2SI†)
support the non-occurrence of intraR IHB (type b in Fig. 4
and 6).
No significant changes in Δδ (Table 2 and Fig. 11b) and in
the signal patterns of EtO-groups (protons labelled a in
Fig. 3SI†) are observed for RR/SS-6 and RR/SS-7, pointing to the
absence of interR IHB (type c in Fig. 4). By contrast, significant
changes in the signal patterns of aromatics are observed
between RR/SS-6 and RR/SS-7 in benzene-d6, whereas very
similar signal patterns for RS/SR-6 and RS/SR-7 are observed
(Fig. 12) in DMSO-d6, i.e., the absence of any type of IHB, sup-
porting the occurrence of intraR IHB in RR/SS-6 in benzene-d6
(Fig. 10b).
Protonation of alkoxyamines
Alkoxyamines 4–7 carry a pyridyl moiety on the alkyl fragment
suitable for activation by protonation. Consequently, protona-
tion in benzene-d6 (model for tert-butylbenzene t-BuPh) in the
presence of trifluoroacetic acid is confirmed by changes in 1H
NMR shifts in the aromatic zone, e.g. RR/SS-4 (Fig. 4SI†). The
values of pKa (Table 3)
39 are estimated from the 1H NMR shift
of the signal in the aromatic zone, e.g., RR/SS-4 (Fig. 13), and
are given by the modified Hasselbach–Henderson equation
(eqn (1), exemplified by 4/4H+, and Table 3).40,41
δpH ¼ δ4 þ δ4Hþ  δ41þ 10pKapH ð1Þ
As already reported, the pKa of 12 is ca. 1.7–1.9 units lower
than that reported for the ortho-ethylpyridine. It is ascribed to
the presence of the nitroxyl fragment as a strong electron with-
drawing group (EWG). The one unit lower pKa for the ortho-
hydroxyethylpyridine is also ascribed to the presence of the
OH group as an EWG. Therefore, the lower pKa values for 4–7
(Fig. 13) than those for ortho-ethylpyridine and ortho-hydroxy-
ethylpyridine are due to the presence of the nitroxyl fragment
as an EWG. It is noteworthy that alkoxyamines 4–6 exhibit pKa
values very close to those for model 12, except for RR/SS-6.
The one unit lower pKa value for 7 than that for 12 is
ascribed to the acylated hydroxyl group, which exhibits a
higher electron withdrawing property than the OH group, the
basicity of the pyridine moiety being thus decreased.
Kinetic investigations
Homolysis rate constants kd,T were measured using either the
31P NMR method27 for 4, 4H+, 5, 7 and 7H+ or the EPR
method20 for 2, 2′, 2″, 3′, 6 and 6H+, as previously reported.
Differences in Ea observed between diastereoisomers for 2, 2′,
2″, 3, 5 and 7 in t-BuPh as a solvent are in the range of
Fig. 11 31P NMR signals in various solvents for (a) a (2 : 1) mixture of RR/
SS-6 (left) and RR/SS-7 (right), and (b) a (2 : 1) mixture of RS/SR-6 (left)
and RS/SR-7 (right).
Table 2 Solvent effect on diastereoisomers of 6 and 7 investigated by
31P NMR
Solventa βb
δ (ppm)
Δδd
(ppm)
δ (ppm)
Δδd
(ppm)
RR/
SS-6 c
RR/
SS-7 c
RS/
SR-6 c
RS/
SR-7 c
CDCl3 0.10 24.48 24.48 0.0 27.27 25.30 1.97
C6D6 0.10 24.52 24.32 0.20 26.90 24.82 2.08
CD3CN 0.40 24.64 24.47 0.17 27.25 25.19 2.06
Acetone-
d6
0.48 24.63 24.34 0.29 27.65 25.62 2.03
CD3OD 0.66 25.51 25.27 0.24 27.65 26.05 1.60
DMSO-
d6
0.76 24.45 24.08 0.37 26.97 25.30 1.67
a 85% H3PO4 was used as an internal reference (0 ppm).
bHydrogen
bond acceptor parameter β. Given in ref. 30. c Ratio 6 : 7 = 2 : 1. dΔδ =
δ6 − δ7.
Fig. 10 Possible conformations affording intraN IHB for RS/SR-4 (a)
and intraR IHB for RR/SS-6 (b). Fig. 12 1H NMR spectra of RR/SS-6 (top) and RR/SS-7 (bottom) in the
range 3–6 ppm (top row) and 6–9 ppm (pyridyl proton zone, bottom
row) in CDCl3 (left) and DMSO-d6 (right). Labelling of protons: a–e rep-
resent MeCH2O, CHP, CHMe, OH, and CH2O, respectively.
Organic & Biomolecular Chemistry Paper
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0–2 kJ mol−1 – generally observed for diastereoisomers
reported in the literature – and do not deserve more com-
ments.36 Alkoxyamines exhibiting IHB are discussed later.
Except for 6, comments made for diastereoisomers in t-BuPh
as a solvent hold in water, as IHB is suppressed.
DFT calculations
DFT calculations at the M062X/6-31+G(d,p) level of theory in
the gas phase were performed to determine both the thermo-
dynamics of the homolysis and the most stable conformations
for the diastereoisomers of 2–4 and 6 (Table 1SI†).42 Important
geometrical parameters – bond lengths, distances and angles –
are reported in Table 1SI† and agree with X-ray data and those
reported for molecules of the same family, except for the
occurrence of IHB in RR/SS-4. Thermodynamics of 4 and 6
show the same trends as that experimentally reported
(Table 1SI†). Only the 3 most stable conformations A, B and
C †† are reported for 4 and 6 (Fig. 14). Valence angles, bond
lengths and distances for IHB are reported in Table 5.
Depending both on the valence angle α and on the distance
dH⋯X between the H and X atoms implied in the H-bonding,
IHB is given as strong (α > 150° and d smaller than the sum of
van der Waals radii of H and X atoms), as weak (α < 120° and d
closer to the sum of the van der Waals radii of H and X atoms)
or as medium for other combinations.¶ 37,38 On these grounds,
IHB for the most stable conformers is considered as strong for
RS/SR-6 (conformer A) and RS/SR-9, and as medium for other
diastereoisomers (Fig. 14 and Table 5). For all cases, IHB is
smaller by ca. 1.8 Å and by 0.5 Å for OH⋯OvP and for OH⋯N
interactions, respectively, than the respective sums of van der
Waals radii¶ – dOH⋯OP = 2.61 Å and dOH⋯N = 2.64 Å – and all
valence angles α are larger than 130°. Nevertheless, the occur-
rence of IHB is controlled mainly by the steric hindrance. As
illustrated by RR/SS-9, when steric hindrance is too large, IHB
does not occur, and in some cases, for example, RR/SS-4 and
RR/SS-6, the most stable conformer B does not display the
strongest IHB.‡‡ All other possible IHBs are disregarded due
to distances dOH⋯OP and dOH⋯N much larger than the sums of
the van der Waals radii, except for OH⋯NO for the conformer
C of RS/SR-6. Nonetheless, the IHB observed between the
hydroxyl group and the N atom of the nitroxyl moiety in the
conformer C is not strong enough to balance the steric strain
in C, which is less stable than A by 19 kJ mol−1 (Fig. 14).
Discussion
Free motions in the nitroxyl fragment
Taking into account (i) NMR observations for RR/SS-4 denoting
the simultaneous occurrence of intraN and interN IHBs
(Fig. 4), (ii) calculations ascribing these two IHBs to two
different conformers (Fig. 14 and Table 5), (iii) dramatically
restricted bond rotations in the group carrying the diethyl-
phosphoryl group attached to the nitroxyl moiety in nitroxides,
and in the subsequent alkoxyamines,§§ 43–45 the question of
the free rotation around the C–N bond for the other alkyl
group attached to the nitroxyl moiety is raised. Indeed, the
conformations of the nitroxyl fragment are expected to be
ruled by the conformations of the nitroxide, as highlighted by
the occurrence of the same IHB in 3• 26 and 3.27 Whatever the
route for the preparation of 2 and 3 (Scheme 2 and ESI†), 1H
NMR spectra of intermediates are the same (see the ESI†) as
well as kd values within the experimental error (Table 4), sup-
porting that for the group carrying the hydroxyl function, the
rotation of the C–N bond is free, whereas the rotation of the
C–N bond for the moiety carrying the diethylphosphoryl group
Table 3 Values of pKa for 4–7
4 5 6 7
RR/SS RS/SR RR/SS RS/SR RR/SS RS/SR RR/SS RS/SR
pKa
a,b 4.08c 4.32c 3.81c 4.25c 4.25c,d 3.61c,d 3.24c,d 3.33c,d
a All pH values measured in D2O/MeOH-d4 (1 : 1) were re-estimated using pH = 0.929·pH* + 0.42. pH* is the pH measured in D2O/MeOH-d4 solu-
tions using a pH-meter calibrated with non-deuterated water. See ref. 39. b pKa = 5.89 for ortho-ethylpyridine. See ref 40.
c pKa = 4.85 for ortho-2-
hydroxyethylpyridine. See the ESI. d pKa values of 4.21 (RS/SR) and 3.99 (RR/SS) were reported for 12. See ref. 41.
Fig. 13 Titration curves for RR/SS-4 (0.01 M, ■, inset: signal of the aro-
matic proton zone) and RS/SR-4 (0.01 M, ●), D2O/MeOH-d4 = 1 : 1.
††Conformer A exhibiting IHB between HO and PvO functions, conformer B
exhibiting IHB between the OH function and N atom, and C the most stable con-
former with no IHB.
‡‡ Indeed, conformer A exhibits geometrical parameters (Table 5) featuring
stronger IHB than in B as highlighted by the shorter dOH⋯OP and flatter angle α
for RR/SS-6.
§§When the t-Bu group attached to the nitroxyl moiety is replaced by a bulkier
group CMe2R, no difference in kd is observed, meaning that the nitroxyl frag-
ment adopts a conformation which forces the R group to be in such a position
that its bulkiness is cancelled. This is due to the levelled steric effect. See ref.
43–46.
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Fig. 14 Most stable conformations A–C†† for RR/SS-4, RS/SR-4, RR/SS-6, and RS/SR-6. All conformers are on the same energetic scale (kJ mol−1).
Dotted lines for the difference in energy between isomers and full lines for the difference in energy between conformers.
Table 4 C–ON bond homolysis rate constant kd,T at various temperatures T for alkoxyamines under various conditions of solvents and pH and their
corresponding activation energies Ea, the homolysis rate constant kd re-estimated at 120 °C and predicted activation energies E’a
Solvent T (°C)
RR/SS RS/SR E′a
a,b
References jkd,T
c,d Ea
b,e kd
f,g kd,T
c,d Ea
b,h kd
f,i RR/SS RS/SR
2 k,l t-BuPh 90 3.0 124.4 7.1 3.5 123.9 8.2 —m —m t.w.
2′ l,n t-BuPh 100 9.4 124.3 7.3 10.5 124.0 8.0 n.d. n.d. t.w.
2″ l,o t-BuPh 90 3.2 124.2 7.6 3.5 124.0 8.0 n.d. n.d. t.w.
3 l t-BuPh n.m. n.m. 122.5 12.5 n.m. 121.8 15.5 —p —p 29
3′ l,n t-BuPh 100 14.7 122.9 11.2 16.7 122.5 12.7 n.d. n.d. t.w.
4 q t-BuPh 80 4.1 120.1 26.1 2.4 121.7 16.0 122.5r 122.8r t.w.
4H+ q t-BuPhs 50 0.8 114.3 154.1 0.6 115.3 113.5 112.2t 113.8t t.w.
5 q t-BuPh 100 110.0 123.7 8.7 220.0 121.7 16.0 124.4u 124.9u t.w.
5H+ q t-BuPh 50 1.3 113.1 225.4 1.0 113.7 187.6 115.8t 113.8t t.w.
6 l t-BuPh 100 23.7 121.5 17.0 2.9 128.0 2.3 123.4v 128.9v t.w.
6H+ l t-BuPhs 83 11.8 117.9 51.2 1.2 124.8 6.2 113.6t 120.1t t.w.
7 q t-BuPh 83 2.8 122.2 13.7 4.4 120.9 20.4 123.0w 124.9w t.w.
7H+ q t-BuPhs 61 0.5 119.2 34.9 0.8 118.3 45.9 114.1t 117.0t t.w.
8 t-BuPh n.m. n.m. 123.2 10.1 n.m. 122.7 11.8 n.d. n.d. 27
9 t-BuPh n.m. n.m. 123.4 9.5 n.m. 129.9 1.3 —x —x 29
10 t-BuPh n.m. n.m. 123.0 10.7 n.m. 123.9 8.1 —y —y 29
11 t-BuPh n.m. n.m. 124.0 7.9 n.m. 123.0 10.7 —z —z 29
12 t-BuPh n.m. n.m. 124.1 7.8 n.m. 123.8 8.4 —aa —aa 41
12H+ t-BuPh n.m. n.m. 116.0 n.m. 116.2 n.d. n.d. 41
3 —ab n.m. n.m. 125.1 5.7 n.m. 122.8 11.4 —ac —ac 27
4 q pH = 7.0ad 80 8.3 118.0 49.6 12.8 116.8 71.7 121.3ae 123.6ae t.w.
4H+ q pH = 1.4ad 50 4.6 109.6 649.3 4.9 109.4 690.3 104.5af 103.3af t.w.
6 l pH = 7.0ad 93 14.9 120.3 24.6 5.0 124.1 7.7 118.4ag 124.8ag t.w.
6H+ l pH = 1.4ad 72 14.6 113.8 179.6 12.8 114.2 158.9 106.8af 110.6af t.w.
8 —ab n.m. n.m. 123.8 8.4 n.m. 123.2 10.1 n.d. n.d. 29
9 —ab n.m. n.m. 122.2 13.7 n.m. 124.4 7.0 —ah —ah 29
11 —ab n.m. n.m. 123.0 10.7 n.m. 124.0 7.9 —z —z 29
12 —ab n.m. n.m. 121.4 17.5 n.m. 122.5 12.5 —ai —ai 41
12H+ —ab n.m. n.m. 108.0 n.m. 109.0 n.d. n.d. 41
a Predicted values of Ea using the incremental scale.
b In kJ mol−1. c In 10−4 s−1. dGiven by eqn (4). e Estimated using kd values in the 4
th column and
the frequency factor A = 2.4 × 1014 s−1 in eqn (5). See ref. 51. f In 10−3 s−1. g Estimated using Ea values in the 5
th column and the frequency factor A =
2.4 × 1014 s−1 in eqn (5). See ref. 51. h Estimated using kd values in the 7
th column and the frequency factor A = 2.4 × 1014 s−1 in eqn (5). See ref. 51.
i Estimated using Ea values in the 8
th column and the frequency factor A = 2.4 × 1014 s−1 in eqn (5). See ref. 51. j t.w.: this work. n.d.: not determined.
n.m.: not measured. k Prepared via the route 3a → 3b→ 3• → 3→ 2. lMeasured by EPR. mUsed as a model: Δ11→2 = +0.4 kJ mol
−1 for the diastereo-
isomer RR/SS and Δ11→2 = +0.9 for the diastereoisomer RS/SR.
n Prepared via the route 3a→ 2a→ 2b→ 2•→ 2′(2) → 3′ (3). o Prepared via route 3a→
3b→ 2b→ 2• → 2″ (2). pUsed as a model: Δ11→3 = −1.5 for RR/SS and Δ11→3 = −1.2 for RS/SR. q kd determined by 31P NMR. See ref. 20. r E′a = Ea,11 +
Δ11→3 + Δ11→12.
s Protonation is performed by adding 2 eq. of TFA. t Protonation expected to decrease Ea by 7.9 kJ mol
−1, as highlighted by the proto-
nation of 12 in t-BuPh. See ref. 41. u E′a = Ea,11 + Δ11→2 + Δ11→12.
v E′a = Ea,11 + Δ11→9 + Δ11→12.
w E′a = Ea,11 + Δ11→10 + Δ11→10.
xUsed as a model:
Δ11→9 = −0.6 for RR/SS and Δ11→9 = +6.9 for RS/SR. yUsed as a model: Δ11→10 = −1.0 for RR/SS and Δ11→10 = +0.9 for RS/SR. zUsed as a reference.
aaUsed as a model: Δ11→12 = 0 for RR/SS and Δ11→12 = +1.0 for RS/SR.
abH2O :MeOH (1 : 1) is used as a solvent.
acUsed as a model: Δ11→3 = +1.1 for
RR/SS and Δ11→3 = +0.2 for RS/SR.
adWater as a solvent. ae E′a = Ea,11 + Δ11→3 + Δ11→12.
af Protonation expected to decrease Ea by 13.5 kJ mol
−1, as
highlighted by the protonation of 12 in a H2O/MeOH mixture. See ref. 41.
ag E′a = Ea,11 + Δ11→9 + Δ11→12.
ahUsed as a model: Δ11→9 = −1.8 for RR/SS
and Δ11→9 = +1.4 for RS/SR.
aiUsed as a model: Δ11→12 = −2.0 for RR/SS and Δ11→12 = −1.0 for RS/SR.
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is, in general, strongly restricted in the nitroxide,46,47 and
likely in the alkoxyamine.
IHB in alkoxyamines
A quick glance at 3, 4, 6 and 9 shows that several types of IHBs
may occur (Fig. 4). The occurrence of interR IHB for RS/SR-9
has been reported in the literature.29 It has been observed by
X-ray,29 NMR,29 and IR29 and is supported by DFT calculations
and does not deserve more comments, as RS/SR-9 is used as a
model. Diastereoisomer RR/SS-9 does not exhibit IHB.29 The
occurrence of intraN IHB for 3 was recently studied by
NMR¶¶ 27 and supported by DFT calculations in this work (see
the ESI† and Table 5) and does not deserve more comments.
X-ray data, NMR analysis, and DFT calculations support IHB of
type interR, intraR, and intraN (Fig. 4, 8, 10 and 14) for RS/SR-6,
RR/SS-6, and RS/SR-4, respectively (see the ESI†). In contrast
with diastereoisomer RS/SR-6, no IHB is observed in diastereo-
isomer RR/SS-4 by X-ray analysis, although 31P NMR supports
the occurrence of intraN IHB, 1H NMR supports the occurrence
of interN IHB. The appealing 3-center IHB displayed in Fig. 8
is disregarded by DFT calculations (too high energy confor-
mer).∥∥ On the other hand, DFT calculations show a small
difference in energy of 2.5 kJ mol−1 between the stable con-
former B and conformer A, more stable than C by 16 kJ mol−1,
meaning that a fast equilibrium between B and A likely
accounts for the simultaneous occurrence of intraN and interN
IHBs observed by NMR. This fast equilibrium requires fast
bond rotation around the C–N bond of the group carrying the
hydroxy function. This fast rotation is nicely supported both
by the temperature dependence of RR/SS-4 (not shown) and
the kinetics and NMR observations reported for 2 and 3
(vide supra). The small difference in energy of 8 kJ mol−1
between diastereoisomers of 4 agrees with the small difference
of 1.6 kJ mol−1 in Ea.
Influence of IHB on kd
Several linear multiparameter relationships developed over the
last two decades to investigate various effects involved in the
changes in kd
25,36 cannot account for the effect of IHB. In par-
allel with these relationships, the group additivity approach48
provides Ea values predicted with a good accuracy using a scale
developed a decade ago.49 To use the group additivity
approach, alkoxyamine 11 was selected as a benchmark, as it
displays the nitroxyl fragment with the lowest functionalization
in that series and a secondary aromatic alkyl fragment. Thus,
estimated activation energies E′a were determined (Table 4 and
ESI†). Taking into account the small difference in polarity
between the alkyl fragment carrying a pyridyl (σI = 0.06)
50,51 or
a phenyl (σI = 0.07)
52 moiety, no significant difference was
reported,41 and the presence of the hydroxyl group capable of
intraR IHB does not provide more than a 2-fold increase in kd,
as highlighted by the couples 6/9 and 4/3. To unveil the effect
of IHB on kd, the hydroxyl group was protected by silylation in
2 and 5, by methylation in 8, and by acylation in 7 and 10, to
suppress the occurrence of IHB (see the ESI†). Kinetic results
Table 5 Valence angles α <OHOP> and <OHN>, and distances dOH⋯OP and dOH⋯N for conformers A,
a B,b and C c of diastereoisomers of 4 and 6
Alkoxyamine Conformer
αd (°) Distancesd (Å)
ΔIHB
e<OHOP> <OHN> dOH⋯OP dOH⋯N
RR/SS-3 Aa 148 — j 1.83 —e −0.7 f
RS/SR-3 Aa 150 — j 1.83 —e −0.9 f
RR/SS-4 Aa 148 —g 1.83 6.55 −3.6h
Bb —g 149 6.25 2.06 n.e.
Cc —g —g 6.79 6.87 n.e.
RS/SR-4 Aa 146 —g 1.85 6.61 0h
Bb —g 161 4.78 2.13 n.e.
Cc —g —g 6.68 8.05 n.e.
RR/SS-6 Aa 170 —g 1.82 5.09 n.e.
Bb —g 136 5.16 2.11 −0.7i
Cc —g —g 6.65 4.82 n.e.
RS/SR-6 Aa 173 —g 1.79 4.56 +7.1i
Bb —g 136 4.99 2.03 n.e.
Cc —g — j,k 4.91 4.84k n.e.
RR/SS-9 Cc —g — j 6.00 — j n.e.
RS/SR-9 Ab 174 — j 1.79 — j +6.0l
RR/SS-4 X-ray —g —g 6.63 6.91 n.e.
RS/SR-6 X-ray 164 —g 1.96 4.29 n.e.
a Conformer exhibiting IHB between HO and PvO functions. b Conformer exhibiting IHB between OH and N functions. c The most stable confor-
mer with no IHB. d Bold values denote the most stable conformers. e In kJ mol−1. n.e. not eligible. f ΔIHB = Ea,3 − Ea,8. gNot given because of too
long dH⋯X forbidding any IHB. See ref. 38.
h ΔIHB = Ea,4 − Ea,5. See the ESI. i ΔIHB = Ea,6 − Ea,7. See the ESI. jNot available. k A medium strength
IHB between the HO group and the N-atom of the nitroxyl moiety is observed: dOH⋯N = 1.99 Å and <OHN> = 140°.
l ΔIHB = Ea,9 − Ea,10. See the
ESI.
¶¶ In ref. 29, no intraN IHB is observed in X-ray data.
∥∥ Indeed, a 3-center IHB (Fig. 8) would require a conformation for the aromatic
ring exhibiting a 1,3-syn allylic destabilizing interaction with H10, whereas such
an interaction does not occur for conformers A and B.
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showed that the 4 types of IHBs can be gathered into two main
families: alkyl and nitroxyl fragments exhibiting intra IHB
which show no significant differences (less than a factor 2)
between the alkoxyamines carrying the free hydroxyl group (3,
RS/SR-4, and RR/SS-6) and those carrying the protected
hydroxyl group (2, RS/SR-5, and RR/SS-7) and inter IHB
between alkyl and nitroxyl fragments which shows a clear 6–9-
fold decrease in kd between the alkoxyamines carrying the free
hydroxyl group (diastereoisomers RS/SR of 6 and 9) and those
carrying the protected hydroxyl group (diastereoisomers RS/SR
of 7 and 10). Deeper insights into the geometrical parameters
– the IHB valence angle α <OHX> and the IHB distance dOH⋯X
– ruling the strength of the IHB and its influence on kd given
by ΔIHB (see Table 5) are unveiled by the 3D plot f (ΔIHB,d,α) in
Fig. 15. Indeed, intra IHB exhibits a very weak effect (−1 < ΔIHB
< 0 kJ mol−1 except for intraN in RR/SS-4) associated with short
H-bonds (dOH⋯X < 1.9 Å) and closed angles α (α < 150°) denot-
ing medium strength IHB,*** whereas interR IHB exhibits a
strong effect (ΔIHB > 6 kJ mol
−1) associated with short H-bonds
(dOH⋯X ≈ 1.8 Å) and open angles α (α ≈ 175°) denoting strong
IHB. As mentioned above, diastereoisomer RR/SS-4 simul-
taneously displays intraN and interN IHBs and, thus, the decay
of RR/SS-4 is described in Scheme 5 with K1 = k1/k−1 for the
equilibrium constant between interN and intraN conformers,
and k2 and k3 the rate constants for the homolysis of interN
and intraN conformers, respectively. Taking into account that
interN IHB makes a bond between nitroxyl and alkyl fragments
as interR IHB does, the same effect is expected, i.e., an increase
in Ea in regard to the homologue with no IHB. Therefore, k3
must be smaller than k2 which corresponds to intraN IHB
noted to increase kd (vide supra). Hence, disregarding k3, and
assuming both a fast equilibrium – supported by very close cal-
culated energy levels (vide supra) – between conformers B
(interN) and A (intraN) and the pre-equilibrium assumption
(k−1⋙ k2 and K1 = k1/k−1), kd (considered as the apparent rate)
is given as kd = k1k2/(k−1 + k2) (eqn (2) or as kd = K1k2 as in
eqn (3), Scheme 5). As the decrease in Ea is in the expected
range (see Table 4), the values of kd should be very close to k2,
meaning that K1 ≈ 1 is in good agreement with the value esti-
mated by DFT calculations, i.e., K1 = 0.42.†††
d 3•½ 
dt
¼ k1k2
k1 þ k2 ½interN ð2Þ
d 3•½ 
dt
¼ K1k2½interN ð3Þ
Solvent effect on kd
The solvent effect in alkoxyamines does not increase too much
interest despite the very amazing results recently reported,
such as a striking 1500-fold increase in kd from t-BuPh to
water as solvents or a slight but clear 5–20-fold increase in kd
for homologue alkoxyamines of 12.53,54 Solvent effects for 3,27
9,29 and 12 41 have been previously reported. Alkoxyamines 4,
6, 9 and 12 show a small ca. 1.5–3-fold increase in kd, as
expected from the literature,53,54 except for RS/SR-4, RS/SR-6
and RS/SR-9. The 3-fold and 5-fold increases in kd for dia-
stereoisomers RS/SR of 6 and 9 are ascribed to the suppression
of IHB from t-BuPh to water/MeOH as solvents. The slight 4.5-
fold increase in kd observed for RS/SR-4, from t-BuPh to water/
MeOH as solvents, might be ascribed to the suppression of sta-
bilizing IHB which balances the steric strain due to the con-
figuration. The unexpected slight ca. 2-fold decrease in kd for 3
is ascribed to a better solvation of the alkoxyamine, and hence a
better stabilization, and higher Ea from t-BuPh to water/MeOH
as solvents than for the other alkoxyamines investigated.
For protonated alkoxyamines 4H+, 6H+ and 12H+, a 3–12-
fold increase in kd is observed and is ascribed to intimate ion
pair dissociation and solvation effects,55 except for RS/SR-6, for
which a 25-fold increase in kd is observed due to the combi-
nation of IHB suppression and intimate ion pair dissociation.
Effect of protonation on kd
A ca. 10-fold and 60-fold increase in kd for 12 in t-BuPh and
water/MeOH as solvents was reported upon protonation.
Amazingly, the protonation effect for 4, i.e., a ca. 6-fold and
Fig. 15 A 3D plot highlighting the relationship between the energetic
effect of IHB ΔIHB (kJ mol
−1), IHB valence angle α (°), IHB distances
dOH⋯X (Å) for the diastereoisomers of 3, 4, 6 and 9. Black and red
symbols are intra and inter fragment IHB, respectively (see Fig. 4). Blue
dots are for projection on the XY plane.
Scheme 5 Equilibrium between interN and intraN IHB and the sub-
sequent homolysis.
***The weak effect of IHB in RR/SS-6 is due to a weak IHB (the weakest of those
investigated), as highlighted by its longest dOH⋯X and its closed angle α.
†††For such molecules, a difference of 2.5 kJ mol−1 in energy is in the limit of
accuracy and reliability of the method.
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12-fold increase in t-BuPh and water/MeOH as solvents,
respectively, and that for 6, i.e., a 3-fold and ca. 8-fold increase
(for the RR/SS diastereoisomer) in t-BuPh and water/MeOH as
solvents, respectively, are less strong than that for 12, although
6 and 4 exhibit structures very similar to that of 12!
Suppressing IHB in water/MeOH for RS/SR-6H+ affords a
20-fold increase in kd upon protonation. This surprising lower
effect of protonation for 4 and 6 is ascribed to the better sol-
vation of the alkoxyamine for 4 and 6 than that for 12, due to
the presence of the hydroxyl group affording the better stabiliz-
ation of the starting alkoxyamine, which partly balances the
polar effect due to protonation.
Experimental section
Alkoxyamines 3 were prepared as previously reported,26 with
the modification of the first step. All solvents and reactants for
the preparation of alkoxyamines were used as received.
Routine reaction monitoring was performed using silica gel 60
F254 TLC plates; spots were visualized upon exposure to UV
light and a phosphomolybdic acid solution in EtOH as a stain
revealed by heating. Purifications were performed on a
Reveleris® X2 flash chromatography system (BUCHI,
Switzerland); a solvent delivery system: high pressure HPLC
pumps; pump flow rate: 1–200 mL min−1; maximum pressure:
200 psi; gradients: linear (see Fig. 5SI† for the profile); UV
wavelength range: 200–500 nm; flash Reveleris® and
GraceResolv™ cartridges: silica 40 μm, silica weight (g): 4, 12,
24, 48, 80 and 120. 1H, 13C, and 31P NMR spectra were
recorded in CDCl3 on a 300 or 400 MHz spectrometer.
Chemical shifts (δ) in ppm were reported using residual non-
deuterated solvents as the internal reference for 1H and
13C-NMR spectra, and as an internal capillary filled with 85%
H3PO4 for
31P-NMR spectra. High-resolution mass spectra
(HRMS) were recorded on a SYNAPT G2 HDMS (Waters)
spectrometer equipped with a pneumatically assisted atmos-
pheric pressure ionization source (API). Positive mode electro-
spray ionization was used on samples: electrospray voltage
(ISV): 2800 V; opening voltage (OR): 20 V; nebulizer gas
pressure (nitrogen): 800 L h−1. Low resolution mass spectra
were recorded on an ion trap AB SCIEX 3200 QTRAP instru-
ment equipped with an electrospray source. The parent ion [M
+ H]+ is quoted.
Diethyl (1-((1-hydroxy-2-methylpropan-2-yl)amino)-2,2-
dimethylpropyl)phosphonate (3b)
Under N2, 2-methyl-2-aminopropanol 3a (6.8 g, 1.1 eq.,
76.7 mmol) was added dropwise to a solution of pivalaldehyde
(6.0 g, 1 eq., 69.7 mmol) in pentane (50 mL). The solution was
heated at 65 °C with a Dean–Stark device for 2 days. Then,
pentane was evaporated and diethylphosphite (10.6 g, 1.1 eq.,
76.7 mmol) was added at r.t., and the mixture was heated at
45 °C for seven days. The solution was acidified with 1 M HCl
(50 mL), and washed with dichloromethane (2 × 30 ml). The
aqueous layer was basified with NaHCO3 and then extracted
with dichloromethane (2 × 20 ml), the organic layer was dried
(MgSO4), and the solvent was evaporated to yield amino-
phosphonate 3b (16.1 g, 78%).26
Diethyl (1-((1-((tert-butyldimethylsilyl)oxy)-2-methylpropan-2-
yl)amino)-2,2-dimethylpropyl) phosphonate (2b)
The same procedure as that for 3b was applied to 2a. 2a (3 g,
1.1 eq., 16.23 mmol), pivalaldehyde (1.27 g, 1 eq.,
14.75 mmol), pentane (20 mL) and diethylphosphite (2.2 g,
1.1 eq., 16.23 mmol). After flash-chromatography (gradient
petroleum ether (PE)/AcOEt: 0% to 100% of AcOEt), amino-
phosphonate 2b was isolated (3.8 g, 64%, colourless oil).
1H NMR (300 MHz, CDCl3) δ: 4.09 (qd, J = 7.1, 1.3 Hz, 4H),
3.32 (s, 2H), 2.81 (d, JH–P = 17.0 Hz, 1H), 1.68 (s, 1H), 1.30 (t,
J = 7.1 Hz, 6H), 1.06 (s, 3H), 1.04 (s, 9H), 0.99 (s, 3H), 0.90 (s,
9H), 0.03 (s, 6H). 13C NMR (75 MHz, CDCl3) δ: 72.8 (d, JC–P =
1.8 Hz), 61.4 (d, JC–P = 7.4 Hz), 61.0 (d, JC–P = 7.6 Hz), 58.9 (d,
JC–P = 138.7 Hz), 54.2 (d, JC–P = 1.6 Hz), 35.2, 35.1, 27.9 (d,
JC–P = 6.2 Hz, 2C), 25.9 (3C), 25.1 (d, JC–P = 1.5 Hz), 24.2, 18.2,
16.5 (d, JC–P = 4.6 Hz), 16.4 (d, JC–P = 5.0 Hz), −5.5 (2C).
31P NMR (162 MHz, CDCl3) δ: 30.09. HRMS m/z (ESI) calcd for
C19H45NO4PSi [M + H]
+ 410.2850, found: 410.2852.
(1-(Diethoxyphosphoryl)-2,2-dimethylpropyl)-(2-
((tert-butyldimethylsilyl)oxy)-1,1-dimethylethyl)amino-N-oxyl
radical (2•)
Aminophosphonate 2b (1.0 g, 1 eq., 2.4 mmol) was dissolved
in a mixture of EtOH/H2O (3 : 1) (15 mL) and Na2CO3 (1.55 g,
6 eq., 14.6 mmol). Then, Oxone® (3.0 g, 4 eq., 9.8 mmol) was
added in small portions at r.t. within 2 h under vigorous stirring.
After completion, Et2O (10 ml) was added, and the precipitate
was filtered off. Et2O was removed under vacuum.
The aqueous phase was extracted with dichloromethane
(2 × 15 ml), and dried over MgSO4 and the solvents were evap-
orated under reduced pressure. The crude was purified by
flash chromatography (gradient PE/AcOEt: 0% to 100% of
AcOEt) and nitroxide 2• was isolated (529 mg, 51%). HRMS m/z
(ESI) calcd for C19H44NO5PSi· [M + H]
+ 425.2721, found:
425.2720.
Diethyl (1-((1-((tert-butyldimethylsilyl)oxy)-2-methylpropan-
2-yl)(1-phenylethoxy)amino)-2,2-dimethylpropyl)
phosphonate (2)
To a suspension of CuBr (55 mg, 0.55 eq., 0.388 mmol) and Cu
powder (49 mg, 1.1 eq., 0.78 mmol) in degassed benzene
(argon bubbling for one hour) (3 mL) was added N,N,N′,N′,N″-
pentamethyldiethylenetriamine (80 μL, 0.55 eq., 0.39 mmol).
After stirring for 10 min, a solution of nitroxide 2• (300 mg,
1 eq., 0.71 mmol) and (1-bromoethyl)benzene (103 μL, 1.1 eq.,
0.78 mmol) in degassed benzene (3 mL) was transferred to the
first solution. The mixture was allowed to stir for 12 h. The
solution was diluted with Et2O, quenched with a NH4Cl sat.
solution, washed with water and brine, and dried over MgSO4.
The solvents were evaporated under reduced pressure to give
the crude product as a 1 : 1 mixture of diastereoisomers
(31P-NMR ratio). The crude product was purified by automatic
Paper Organic & Biomolecular Chemistry
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flash-chromatography (gradient PE/AcOEt: 0% to 100% of
AcOEt) to yield alkoxyamines RR/SS-2 (pale yellow oil, 119 mg,
32%) and RS/SR-2 (pale yellow oil 123 mg, 33%). RS/SR-2
1H NMR (300 MHz, CDCl3) δ: 7.37 (d, J = 7.3 Hz, 2H), 7.17 (m,
3H), 5.18 (q, J = 6.4 Hz, 1H), 3.86 (m, 2H), 3.69 (d, JH–P =
26.6 Hz, 1H), 3.58 (s, 2H), 3.38 (m, 1H), 3.21 (m, 1H), 1.48 (d,
J = 6.5 Hz, 3H), 1.15 (m, 18H), 0.86 (m, 12H), 0.00 (s, 6H). 13C
NMR (75 MHz, CDCl3) δ: 143.2, 127.9 (2C), 127.7 (2C), 127.3,
78.5, 70.0 (d, JC–P = 139.2 Hz), 69.0, 65.1, 61.6 (d, JC–P = 6.4 Hz),
58.5 (d, JC–P = 7.5 Hz), 35.4 (d, JC–P = 5.3 Hz), 30.5 (d, JC–P =
6.0 Hz, 2C), 25.9 (3C), 23.4, 22.6, 21.2, 18.2, 16.3 (d, JC–P =
5.6 Hz), 16.1 (d, JC–P = 6.9 Hz), −5.4, −5.5. 1P NMR (121 MHz,
CDCl3) δ: 24.98. RR/SS-2
1H NMR (300 MHz, CDCl3) δ: 7.45 (m,
5H), 5.13 (d, J = 6.8 Hz, 1H), 4.53 (m, 1H), 4.22 (m, 3H), 3.86
(d, JH–P = 26.5 Hz, 1H), 3.24 (q, J = 9.9 Hz, 2H), 1.74 (d, J =
6.7 Hz, 3H), 1.49 (m, 6H), 1.40 (s, 9H), 1.06 (s, 3H), 1.03 (s,
3H), 0.98 (s, 9H), 0.00 (s, 6H). 13C NMR (75 MHz, CDCl3) δ:
145.5, 128.2 (2C), 127.1, 126.8 (2C), 85.4, 69.7 (d, J = 138.1 Hz),
69.6 (d, J = 1.6 Hz), 65.3, 61.6 (d, J = 6.3 Hz), 58.8 (d, J =
7.5 Hz), 35.7 (d, J = 6.1 Hz), 29.9 (d, J = 5.8 Hz, 2C), 25.8 (3C),
24.5, 23.7, 22.1, 18.0, 16.8 (d, J = 5.4 Hz), 16.2 (d, J = 6.7 Hz),
−5.5, −5.6. 31P NMR (121 MHz, CDCl3) δ: 26.19. HRMS for RR/
SS-2 and RS/SR-2 mixture m/z (ESI) calcd for C27H53NO5PSi
[M + H]+ 530.3425, found: 530.3425.
General procedure for TBS protection of alcohols 3a, 3b and
3 32,56
In a flask under N2, alcohols 3a, 3b or 3 (1.0 eq.), tert-butyldi-
methylsilyl trifluoromethanesulfonate (1.5 eq.) and 2,6-luti-
dine (2 eq.) were stirred in dichloromethane at room tempera-
ture for 4 hours. A saturated NaHCO3 solution was added and
the layers were separated. The organic layer was dried over
Na2SO4, filtered, and concentrated in vacuo. Purification was
performed using flash chromatography, affording 2a, 2b, or 2
as an oil.
Hydrolysis31 of silylated compound 2
In a flask under N2, RR/SS-2 or RS/SR-2 (30 mg, 1 eq.,
0.06 mmol) was dissolved in THF (2 mL), and tetra-n-butylam-
monium fluoride (1 M in THF) was added (68 μL, 1.2 eq.,
0.07 mmol). After stirring for 1 hour at room temperature,
THF was evaporated under reduced pressure and the crude
was purified by automatic flash-chromatography (gradient PE/
AcOEt: 0% to 100% of AcOEt) to yield alkoxyamine RR/SS-3′ or
RS/SR-3′ with a yield higher than 90%.
Diethyl-(1-((1-hydroxy-2-methylpropan-2-yl)(1-(pyridin-2-yl)
ethoxy)amino)-2,2-dimethylpropyl) phosphonate (4)
In an open flask, MnCl2 (70 mg, 0.05 eq., 0.35 mmol) was
added to a stirred solution of salen ligand (130 mg, 0.05 eq.,
0.35 mmol) in i-PrOH. After 30 minutes of stirring at room
temperature, a solution of 3• (2.2 g, 1 eq., 7.1 mmol) and
2-vinylpyridine (1.15 mL, 1.5 eq., 10.6 mmol) in i-PrOH was
added first, and then solid NaBH4 (1.07 g, 4 eq., 28.4 mmol)
was added in small portions. The resulting suspension was
stirred at room temperature for 4 h. It was then diluted with
EtOAc and 1 M aq. HCl was carefully added. Solid NaHCO3
was then added until neutralization. The layers were separated,
and the organic phase was washed with water and brine, and
dried over Na2SO4. The solvent was evaporated to give the
crude product as a 1 : 2 mixture of diastereoisomers (31P-NMR
ratio). The diastereomers were separated by automatic flash
column chromatography (gradient PE/AcOEt: 0% to 100% of
AcOEt) to afford RR/SS-4 (pale yellow crystal 560 mg, 19%) and
RS/SR-4 (pale yellow oil 1.01 g 35%). RS/SR-4 1H NMR
(300 MHz, CDCl3) δ: 8.44 (dd, J = 5.1, 1.7 Hz, 1H), 7.59 (td, J =
7.7, 1.8 Hz, 1H), 7.45 (d, J = 7.8 Hz, 1H), 7.07 (ddd, J = 7.6, 4.8,
1.2 Hz, 1H), 5.20 (q, J = 6.5 Hz, 1H), 3.89 (d, J = 12.7 Hz, 1H),
3.67 (m, 4H), 3.57 (d, JH–P = 26.5 Hz, 1H), 3.44 (d, J = 12.6 Hz,
1H), 1.57 (d, J = 6.6 Hz, 3H), 1.12 (s, 3H), 1.10 (s, 9H), 1.09 (s,
3H), 1.04 (t, J = 7.1 Hz, 3H), 0.98 (t, J = 7.1 Hz, 3H). 13C NMR
(75 MHz, CDCl3) δ: 162.1, 148.6, 136.9, 122.3, 121.6, 78.7, 70.5
(d, JC–P = 136.3 Hz), 70.0, 64.9, 61.7 (d, JC–P = 6.6 Hz), 60.1 (d,
JC–P = 7.9 Hz), 35.3 (d, JC–P = 4.0 Hz), 30.6 (d, JC–P = 5.7 Hz, 3C),
26.9, 22.0, 20.4, 16.4 (d, JC–P = 5.7 Hz), 15.9 (d, JC–P = 6.8 Hz).
31P NMR (121 MHz, CDCl3) δ: 26.13. HRMS m/z (ESI) calcd for
C20H38N2O5P [M + H]
+ 417.2513, found: 417.2513. RR/SS-4
1H NMR (400 MHz, CDCl3) δ: 8.49 (m, 1H), 7.66 (td, J = 7.7, 1.8
Hz, 1H), 7.43 (d, J = 7.9 Hz, 1H), 7.15 (ddd, J = 7.6, 4.9, 1.2 Hz,
1H), 5.09 (q, J = 6.7 Hz, 1H), 4.64 (s, 1H), 4.17 (m, 4H), 3.62 (d,
JH–P = 26.4 Hz, 1H), 3.49 (d, J = 12.3 Hz, 1H), 3.04 (d, J =
12.4 Hz, 1H), 1.54 (d, J = 6.7 Hz, 3H), 1.33 (t, J = 7.1 Hz, 6H),
1.18 (s, 9H), 1.02 (s, 3H), 0.68 (s, 3H). 13C NMR (101 MHz,
CDCl3) δ: 164.2, 148.7, 136.7, 122.4, 121.7, 86.3, 69.6 (d, JC–P =
136.1 Hz), 67.5, 65.1, 62.0 (d, JC–P = 6.6 Hz), 60.6 (d, JC–P =
7.8 Hz), 35.8 (d, JC–P = 4.6 Hz), 30.1 (d, JC–P = 5.7 Hz, 3C), 26.8,
23.6, 23.2, 16.6 (d, JC–P = 5.7 Hz), 16.4 (d, JC–P = 6.6 Hz).
31P NMR (162 MHz, CDCl3) δ: 27.29. HRMS m/z (ESI) calcd for
C20H38N2O5P [M + H]
+ 417.2513, found: 417.2515.
Diethyl ((R)-1-((1-hydroxy-2-methylpropan-2-yl)((S)-1-(pyridin-
2-yl)ethoxy)amino)-2,2-dimethylpropyl)phosphonate (RS/SR-5)
Alkoxyamine RS/SR-4 (400 mg, 1 eq., 0.96 mmol) was dissolved
in 20 mL THF, and pyridine was added (388 μL, 5 eq.,
4.80 mmol). Silver nitrate (244 mg, 1.5 eq., 1.44 mmol) was
added and after stirring for 5 minutes, t-butyldimethylsilyl
chloride (217 mg, 1.5 eq., 1.44 mmol) was added and stirring
was continued at room temperature overnight. At the end of
the reaction period, the solution was washed with 10%
NaHCO3 solution and extracted with DCM. The combined
organic phases were dried with MgSO4 and the solvent was
evaporated. The crude product was purified by flash chromato-
graphy (petroleum ether/AcOEt 7 : 3) to afford RS/SR-5 (pale
yellow oil, 341 mg, 67%).1H NMR (400 MHz, CDCl3) δ: 8.52
(ddd, J = 4.9, 1.8, 0.9 Hz, 1H), 7.60 (m, 2H), 7.11 (ddd, J = 7.3,
4.8, 1.5 Hz, 1H), 5.26 (q, J = 6.6 Hz, 1H), 3.87 (m, 2H), 3.77 (d,
JH–P = 26.7 Hz, 1H), 3.71 (m, 1H), 3.63 (s, 2H), 3.57 (m, 1H),
1.58 (d, J = 6.6 Hz, 3H), 1.17 (m, 18H), 1.03 (t, J = 7.1 Hz, 3H),
0.91 (s, 9H), 0.04 (2s, 6H). 13C NMR (101 MHz, CDCl3) δ: 162.5,
148.6, 136.1, 122.5, 122.1, 79.9, 69.8 (d, JC–P = 137.0 Hz), 69.2,
65.4, 61.3 (d, JC–P = 6.4 Hz), 59.1 (d, JC–P = 7.6 Hz), 35.5 (d,
JC–P = 5.1 Hz), 30.3 (d, JC–P = 5.9 Hz), 25.9 (5C), 23.2, 22.8, 20.2,
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18.3, 16.4 (d, JC–P = 5.8 Hz), 16.1 (d, JC–P = 7.0 Hz), −5.4 (2C).
31P NMR (162 MHz, CDCl3) δ: 25.22. HRMS m/z (ESI) calcd for
C26H52N2O5PSi [M + H]
+ 531.3378, found: 531.3380.
Diethyl((R)-1-((1-hydroxy-2-methylpropan-2-yl)((R)-1-(pyridin-2-
yl)ethoxy)amino)-2,2-dimethylpropyl)phosphonate (RR/SS-5)
The same procedure as that for RS/SR-5 was applied to RR/SS-
4. RR/SS-4 (210 mg, 1 eq., 0.5 mmol), 10 mL THF, pyridine
(203 μL, 5 eq., 2.52 mmol), silver nitrate (128 mg, 1.5 eq.,
0.76 mmol), t-butyldimethylsilyl chloride (114 mg, 1.5 eq.,
0.76 mmol). RR/SS-5 (pale yellow oil, 157 mg, 59%). 1H NMR
(400 MHz, CDCl3) δ: 8.53 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H), 7.66
(td, J = 7.7, 1.8 Hz, 1H), 7.34 (d, J = 7.8 Hz, 1H), 7.15 (ddd, J =
7.5, 4.9, 1.2 Hz, 1H), 5.13 (q, J = 6.8 Hz, 1H), 4.37 (m, 1H), 4.09
(m, 3H), 3.73 (d, JH–P = 26.2 Hz, 1H), 3.12 (s, 2H), 1.59 (d, J =
6.8 Hz, 3H), 1.36 (t, J = 7.1 Hz, 3H), 1.30 (t, J = 7.1 Hz, 3H), 1.23
(s, 9H), 0.88 (s, 3H), 0.83 (s, 3H), 0.81 (s, 9H), −0.14 (2s, 6H).
13C NMR (75 MHz, CDCl3) δ: 164.5, 148.8, 136.2, 122.1, 121.7,
86.4, 69.8 (d, JC–P = 138.3 Hz), 69.3 (d, JC–P = 1.4 Hz), 65.4, 61.6
(d, JC–P = 6.4 Hz), 58.9 (d, JC–P = 7.5 Hz), 35.8 (d, JC–P = 6.0 Hz),
29.8 (d, JC–P = 5.8 Hz), 25.8 (3C), 23.3, 23.0, 22.6, 18.1, 16.8 (d,
JC–P = 5.5 Hz), 16.2 (d, JC–P = 6.8 Hz), −5.6 (2C). 31P NMR
(162 MHz, CDCl3) δ: 26.11. HRMS m/z (ESI) calcd for
C26H52N2O5PSi [M + H]
+ 531.3378, found: 531.3380.
2-Bromo-2-(pyridin-2-yl)ethyl acetate (6b)
2-(Pyridin-2-yl)ethyl acetate 6a (2.0 g, 1 eq., 12.0 mmol),
N-bromosuccinimide (2.4 g, 1.1 eq., 13.2 mmol) and benzoyl
peroxide (0.03 g, 0.01 eq., 0.12 mmol) were mixed with CCl4
(100 mL). An argon bubbled solution was refluxed (77 °C). The
reaction was monitored by thin layer chromatography (TLC)
after until complete disappearance of 6a. The solution was
then quenched and washed with NaHCO3 sat., and the
aqueous phases were extracted with CH2Cl2. The combined
organic layers were washed with water, dried over MgSO4 and
concentrated under reduced pressure. The crude product was
subjected to automatic flash-chromatography (gradient PE/
AcOEt: 0% to 100% of AcOEt) to yield bromide 6b (2.02 g,
69%). 1H NMR (400 MHz, CDCl3) δ: 8.59 (d, J = 5.6 Hz, 1H),
7.70 (t, J = 8.6 Hz, 1H), 7.42 (d, J = 7.9 Hz, 1H), 7.28–7.20 (m,
1H), 5.18 (t, J = 7.1 Hz, 1H), 4.73 (d, J = 7.1 Hz, 2H), 2.02 (s,
3H). 13C NMR (101 MHz, CDCl3) δ: 170.3, 156.7, 149.4, 137.3,
123.6, 123.1, 66.3, 49.1, 20.7. HRMS (ESI) calc. for C9H11NO2Br
[M + H]+: 243.9968; found: 243.9967.
Diethyl-(1-(tert-butyl-(2-hydroxy-1-(pyridin-2-yl)ethoxy)amino)-
2,2-dimethylpropyl) phosphonate (6)
To a suspension of CuBr (660 mg, 0.55 eq., 4.6 mmol) and Cu
powder (580 mg, 1.1 eq., 9.1 mmol) in degassed benzene
(argon bubbling for one hour) (30 mL) was added N,N,N′,N′,N″-
pentamethyldiethylenetriamine (1 mL, 0.55 eq., 4.6 mmol).
After stirring for 10 min, a solution of 6• (2.68 g, 1.1 eq.,
9.1 mmol) and bromide 6b (2.0 g, 1 eq., 8.3 mmol) in degassed
benzene (30 mL) was cannulated into the first solution.
The mixture was allowed to stir for 12 h. The solution was
diluted with EtOAc, quenched and washed with 50% (v/v) aq.
ammonia solution and NaHCO3 saturated solution, and dried
over MgSO4. The solvents were evaporated under reduced
pressure. The crude product (1.1 g, 1 eq., 2.4 mmol) with a
1 : 4 diastereomeric ratio (31P NMR ratio) was dissolved in
MeOH (7 mL), and a solution of K2CO3 (663 mg, 2 eq.,
4.8 mmol) in H2O (7 mL) was added at once to the flask. The
solution was allowed to stir for 3 days and then quenched with
water. The aqueous phase was extracted with CH2Cl2 and dried
over MgSO4, and the solvents were evaporated under reduced
pressure. The crude product was subjected to automatic flash-
column chromatography (PE/acetone 7 : 3) to afford RS/SR-6
(144 mg) and RR/SS-6 (490 mg) as colourless oils, corres-
ponding to a total yield of 634 mg (63%). RS/SR-6 1H NMR
(400 MHz, CDCl3) δ: 8.53 (d, J = 4.8 Hz, 1H), 7.64 (t, J = 7.7 Hz,
1H), 7.37 (d, J = 7.7 Hz, 1H), 7.18–7.09 (m, 1H), 5.93 (t, J =
6.9 Hz, 1H), 5.11 (s, 1H), 4.44 (dd, J = 16.5, 7.7 Hz, 1H), 4.28
(dd, J = 16.7, 9.4 Hz, 1H), 4.21–4.09 (m, 2H), 4.02 (dd, J = 15.8,
7.9 Hz, 1H), 3.84 (dd, J = 15.1, 8.5 Hz, 1H), 3.43 (d, JH–P =
27.6 Hz, 1H), 1.38 (t, J = 7.8 Hz, 3H), 1.34 (t, J = 7.6 Hz, 3H),
1.25 (s, 9H), 0.92 (s, 9H). 13C NMR (101 MHz, CDCl3) δ: 160.8,
149.0, 136.0, 122.7, 122.3, 91.0, 68.8 (d, JC–P = 139.6 Hz), 65.0,
62.1, 62.1, 59.8 (d, J = 7.6 Hz), 35.8 (d, J = 5.1 Hz), 30.9 (d, J =
5.8 Hz, 2C), 28.1 (3C), 16.7 (d, J = 5.5 Hz), 16.24 (d, J = 7.0 Hz).
31P NMR (162 MHz, CDCl3) δ: 27.16. HRMS (ESI) calc for
C20H38N2O5P
+: 417.2513 [M + H]+; found: 417.2512. RR/SS-6
1H NMR (400 MHz, CDCl3) δ: 8.48 (d, J = 5.5 Hz, 1H), 7.73 (s,
1H), 7.65 (t, J = 8.5 Hz, 1H), 7.20–7.13 (m, 1H), 5.29 (t, J =
5.6 Hz, 1H), 4.72 (s, 1H), 4.34 (dd, J = 11.2, 5.3 Hz, 1H), 4.01
(dd, J = 11.2, 6.0 Hz, 1H), 3.96–3.83 (m, 2H), 3.73–3.60 (m, 2H),
3.46 (d, JH–P = 26.7 Hz, 1H), 1.25 (s, 9H), 1.21 (s, 9H), 1.13 (t,
J = 7.1 Hz, 3H), 1.03 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz,
CDCl3) δ: 159.7, 148.2, 136.4, 123.3, 122.6, 80.5, 70.2 (d, JC–P =
138.8 Hz), 64.7, 62.2, 61.3 (d, J = 6.7 Hz), 59.8 (d, J = 7.7 Hz),
35.4, 35.3, 30.8 (d, J = 5.9 Hz, 2C), 28.1 (3C), 16.3 (d, J =
6.0 Hz), 16.0 (d, J = 6.9 Hz). 31P NMR (162 MHz, CDCl3) δ:
24.48. HRMS (ESI) calc for C20H38N2O5P
+: 417.2513 [M + H]+;
found: 417.2511.
(S)-2-((tert-Butyl((R)-1-(diethoxyphosphoryl)-2,2-
dimethylpropyl)amino)oxy)-2-(pyridin-2-yl)ethyl acetate
(RS/SR-7)
RS/SR-6 (144 mg, 1 eq., 0.35 mmol) was diluted in CH2Cl2
(5 mL) and triethylamine (0.2 mL, 4 eq., 1.4 mmol) was added.
After 2 minutes, acetic anhydride (0.1 mL, 3 eq., 1.1 mmol)
was added slowly via a syringe. The reaction was allowed to stir
for 3 days and was then quenched with a saturated aqueous
solution of NaHCO3. The solution was extracted with CH2Cl2.
The combined organic extracts were dried with MgSO4, fil-
tered, and concentrated under vacuum. The crude was purified
by automatic flash-column chromatography (petroleum ether/
acetone 9 : 1) to yield RS/SR-7 (140 mg, 90%) as a white solid.
1H NMR (300 MHz, CDCl3) δ: 8.54 (d, J = 4.7 Hz, 1H), 7.66 (t,
J = 7.7 Hz, 1H), 7.36 (d, J = 7.8 Hz, 1H), 7.21–7.12 (m, 1H), 5.30
(dd, J = 7.7, 4.2 Hz, 1H), 4.84 (dd, J = 10.9, 4.2 Hz, 1H),
4.69–4.59 (m, 1H), 4.48–4.33 (m, 1H), 4.21 (td, J = 16.6, 8.9 Hz,
1H), 4.03 (m, J = 17.2, 12.7, 7.2 Hz, 2H), 3.35 (d, JH–P = 26.1 Hz,
Paper Organic & Biomolecular Chemistry
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1H), 1.79 (s, 3H), 1.36 (t, J = 6.4 Hz, 3H), 1.31 (t, J = 7.0 Hz,
3H), 1.23 (s, 9H), 0.87 (s, 9H). 13C NMR (101 MHz, CDCl3) δ:
170.1, 160.1, 148.8, 135.9, 123.3, 122.6, 87.5, 69.5 (d, JC–P =
138.9 Hz), 65.7, 61.8 (2C), 61.7 (d, J = 6.4 Hz), 59.3 (d, J =
7.4 Hz), 35.8 (d, J = 5.4 Hz), 30.1 (d, J = 5.8 Hz, 2C), 28.4 (3C),
20.7, 16.8 (d, J = 5.4 Hz), 16.3 (d, J = 6.8 Hz). 31P NMR
(121 MHz, CDCl3) δ: 25.27. HRMS (ESI) calc for C22H40N2O6P
+:
459.2619 [M + H]+; found: 459.2624.
(R)-2-((tert-Butyl((R)-1-(diethoxyphosphoryl)-2,2-
dimethylpropyl)amino)oxy)-2-(pyridin-2-yl)ethyl acetate
(RR/SS-7)
The same procedure as that for RS/SR-7 was applied to RR/
SS-6. RR/SS-6 (490 mg, 1 eq., 1.18 mmol), CH2Cl2 (10 mL), tri-
ethylamine (0.5 mL, 4 eq., 3.5 mmol), acetic anhydride
(0.3 mL, 3 eq., 3 mmol) flash-column chromatography (PE/
acetone 9 : 1) RR/SS-7 (343 mg, 65%) as a colorless solid.
1H NMR (300 MHz, CDCl3) δ: 8.55 (d, J = 4.8 Hz, 1H), 7.69–7.57
(m, 2H), 7.20–7.08 (m, 1H), 5.35 (dd, J = 6.5, 3.6 Hz, 1H), 4.76
(m, 2H), 3.88 (p, J = 7.2 Hz, 2H), 3.74–3.50 (m, 2H), 3.44 (d,
JH–P = 27.1 Hz, 1H), 1.86 (s, 3H), 1.23 (s, 9H), 1.19 (t, J = 7.1 Hz,
3H), 1.15 (s, 9H), 1.00 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz,
CDCl3) δ: 170.6, 158.1, 148.7, 135.8, 124.6, 122.7, 80.8, 69.6 (d,
JC–P = 138.6 Hz), 64.1, 62.0, 61.4 (d, J = 6.6 Hz), 59.5 (d, J =
7.7 Hz), 35.3 (d, J = 4.4 Hz), 30.7 (d, J = 5.9 Hz, 2C), 28.0 (3C),
20.7, 16.3 (d, J = 5.9 Hz), 16.1 (d, J = 6.8 Hz). 31P NMR
(162 MHz, CDCl3) δ: 24.27. HRMS (ESI) calc for C22H40N2O6P
+:
459.2619 [M + H]+; found: 459.2623.
Kinetic measurements
The values of the homolysis rate constant kd were determined
by monitoring either the concentration of nitroxide by EPR or
the concentration of alkoxyamine by 31P NMR. For EPR, a
sample tube filled with a solution of 10−4 M of each diastereo-
isomer in tert-butylbenzene or in H2O/MeOH (1 : 1) was set in
the EPR cavity. EPR signals were recorded. The temperature
was controlled by using a BVT2000 temperature controlling
unit. Measurements of kd by
31P NMR required the use of
TEMPO as an alkyl radical scavenger. The NMR tubes were
filled with a stock solution of 0.02 M of alkoxyamine in tert-
butylbenzene or in H2O/MeOH with 2 equiv. of TEMPO. Buffer
solutions were used for specific pH conditions instead of H2O.
kd values were given by eqn (4). Activation energies Ea were
estimated using eqn (5) and the average frequency factor A =
2.4 × 1014 s−1. The values of kd and Ea are listed in Table 4.
ln
½alkoxyaminet
½alkoxyamine0
¼ kdt ð4Þ
kd ¼ AeEa=RT ð5Þ
Conclusion
Different types of IHBs exhibiting very different effects are
highlighted. These effects depend on the strength of the IHB,
which in turn is straightforwardly related to its geometric para-
meters – dOH⋯X the distance for IHB and the IHB valence
angle α. That is, strong interR IHBs are expected for α larger
than 160° and dOH⋯X smaller than 1.8 Å affording an increase
in Ea (Tables 4 and 5). As geometric parameters – α ≈ 150° and
dOH⋯X ≈ 2.1 Å – underline a weak IHB, interN IHB does not
exhibit the same effect as that of interR IHB. Indeed, this
interN IHB is weak enough that it is in equilibrium with the
intraN IHB which, in turn, favours slightly the C–ON bond
homolysis, i.e., decreasing Ea. Nevertheless, a strong interN
IHB is expected to afford the same effect as that of a strong
interR IHB. IntraN and intraR IHBs exhibit features of IHB of
intermediate strength – α < 150° and dOH⋯X > 1.8 Å – affording
a decrease in Ea. However, the effect of intraR and intraN
depends a lot on the strength of these IHBs at TS, that is, on
the stereoelectronic requirement for the C–ON bond homolysis
and on the stabilization of the products, i.e., partly due to the
strength of IHB. Hence, stronger IHBs in products than in
starting materials stabilize TS and decrease Ea. This assump-
tion is supported by the stronger IHB in 3• (α = 178° and
dOH⋯X = 1.57 Å) than in 3 and 4 (Table 5).‡‡‡
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As a rule of thumb, one may assume that IHB between alkyl
and nitroxyl fragments (interN or interR IHB) affords an
increase in Ea which might be pictured as the cleavage of two
bonds – C–ON bond and IHB – and that IHB inside each frag-
ment (intraN or intraR IHB) affords a slight decrease in Ea pro-
vided the stabilization due to IHB is larger for the released rad-
icals than that for the starting material. Otherwise, an increase
in Ea might be expected.
This work highlights the combination of several effects –
IHB, solvents, intimate ion pairs, and protonation – to strik-
ingly decrease the alkoxyamine half-life time t1/2, as high-
lighted by t1/2 = 123 days for 6 in t-BuPh as a solvent at 37 °C
and by t1/2 = 14 hours for 6H+ in water/MeOH as a solvent at
37 °C, that is, a 210-fold increase in kd. These results nicely
highlight the potential of such alkoxyamines as switches for
applications in biology.17
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